Gilead Sciences Acquires Tubulis in 315 Billion Deal to Strengthen Oncology Pipeline
TJX Companies Tops List of Dividend Growth Stocks as Analysts Lift Price Targets
Novartis Lifts Annual Sales and Profit Forecast Amid Strong Operational Momentum
US GDP Rose at 2 Annual Rate in First Quarter Signaling Rebound
WTI Crude Oil Forecast Market Watchers Eye Asymmetric Price Swings on IranRelated Headlines
eHealth EHTH Receives Price Target Increase Amid Operational Improvements
Westport Fuel Systems WPRT Q1 2026 Earnings EPS Exceeds Expectations Amid Revenue Uncertainty Stock Declines
PXED Q1 2026 Earnings Strong EPS Beat Drives Stock Higher
OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance
VTGN Q1 2026 Earnings Narrowing Losses as Pipeline Progress Steadies Investor Sentiment
CSGP Q1 2026 Earnings EPS Surges 225 Above Expectations Amidst Modest Stock Decline
Shift4 Payments Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines
Rectitude Holdings RECT Tests Key Support After 366 Decline
Interactive Brokers Group IBKR Faces Headwinds Stock Slides 296 Amid Sector Rotation
Blueport Acquisition Ltd BPAC Holds Steady Near Key Resistance Level
Iamgold IAG Slides 292 Support at 1596 Faces Critical Test
FTAI Aviation Ltd FTAI Surges 23 as Aerospace Momentum Builds Tests Key Resistance Zone
AI Economy Reshapes Labor Market BlueCollar Workers May Gain as WhiteCollar Entry Jobs Slow
Evolution Petroleum EPM Q1 2026 Earnings Steep Earnings Miss Sends Stock Lower
Sally Beauty Holdings SBH Inches Higher as Stock Consolidates Near Key Levels
Nexentis Technologies NXTS Gains 136 as Stock Tests Key Resistance Near 470
Locafy Limited LCFY Retreats 294 as Shares Test Key Technical Levels
Murano Global Investments Warrants MRNOW Plunge Amid Thin Trading Key Levels to Watch
Innovex International INVX Slips 25 as Selling Pressure Builds Near Resistance
SciSparc Ltd SPRC Gains 207 in Light Trading Key Support Holds Above 400
Akamai Technologies AKAM Edges Higher as Bulls Test Resistance Near 157
Agios Pharmaceuticals AGIO Slips 11 as Stock Hovers Near Key Support